Related Experiment Videos
Therapeutic options for chronic obstructive pulmonary disease: present and future
1Department of Medicine, Pulmonary Division, St Paul's Hospital, The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia, Vancouver, BC, Canada.
European Review for Medical and Pharmacological Sciences
|March 5, 2005
Summary
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition. Key therapies include smoking cessation, oxygen, vaccinations, and bronchodilators, with new treatments showing promise.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Therapeutics
Background:
- Chronic obstructive pulmonary disease (COPD) is a significant global health burden, projected as a leading cause of mortality and disability.
- Historically, COPD management was limited, but current understanding highlights its preventability and treatability.
Purpose of the Study:
- To review current and emerging therapeutic strategies for managing Chronic Obstructive Pulmonary Disease (COPD).
- To emphasize the importance of smoking cessation and other established interventions in COPD care.
Main Methods:
- Review of established and novel therapeutic interventions for COPD.
- Discussion of pharmacological and non-pharmacological treatment options.
- Exploration of future therapeutic targets and drug development.
Main Results:
- Smoking cessation is the only intervention proven to slow lung function decline in COPD.
- Domiciliary oxygen therapy improves survival in hypoxemic patients.
- Long-acting bronchodilators and inhaled corticosteroids offer symptomatic relief and clinical benefits.
- Pulmonary rehabilitation and lung transplantation are options for specific patient groups.
Conclusions:
- COPD is a manageable condition with multiple therapeutic avenues.
- Established therapies like smoking cessation and oxygen are crucial.
- Emerging pharmacological agents show potential for disease modification in COPD.